ICHR · Ichor Holdings · Stock research

Price reference: last completed daily close 2026-08-21 at $60.20 (split/dividend-adjusted daily series). 52-week high $112.28, so the shares sit 46.4% under it; the shares are down 12.7% over three months; RSI(14) 26.8.

ICHR — Ichor Holdings, Ltd.

Current Thesis

The leg an investor was buying in Ichor since spring — a memory- and leading-edge-capex re-rating in wafer-fab-equipment subsystems, gas/fluid/chemical delivery modules sold almost entirely into Lam Research and Applied Materials — broke on the 2026-08-03 Q2 print and has now been confirmed broken by price. Revenue of $294.8M missed the $300.166M consensus, the stock reversed from an $80.25 regular-session close to $69.94 after hours, and by 2026-08-07 it closed $68.32. The structural floor under the June advance was the 2026-06-05 low of $62.91. That level is gone: the 2026-08-21 weekly close printed $60.20.

What makes the break informative is what happened in between. Applied Materials reported fiscal Q3 on 2026-08-13 with revenue of $9.115B, up 25% year over year and 15% sequentially, non-GAAP EPS of $3.50, and management raising its Semi Systems growth framing above the prior "greater than 30%" outlook while pointing to leading-edge foundry/logic, DRAM and advanced packaging as roughly 80% of 2026–2027 WFE growth. The single most important external read-through for Ichor improved, and Ichor still made lower lows into 2026-08-21. That is a company-specific and multiple-specific derating rather than a demand-signal derating (INFERRED from the sequence; the demand datapoints are MEASURED and positive).

The narrative is dead for this leg. The narrative's own confirming catalyst arrived on 2026-08-13 and produced no bid, and the price structure that expressed it — the $78 April–May shelf, then the $62.91 June higher-low — is fully unwound. The operating business is not dead; the trade narrative is. A new leg would have to be built on a different claim (gross-margin expansion and cash conversion), and the first evidence for that claim is not dated until the Q3 report, roughly 2026-11-02.

Bullish and bearish views on Ichor Holdings

The model's bull view on Ichor Holdings (ICHR), in brief: Customer capex read-through strengthened, 2026-08-13: Applied Materials posted record revenue of $9.115B (+25% YoY, +15% QoQ) and non-GAAP EPS of $3.50 (+41% YoY), and raised its Semi Systems growth expectation above the prior greater-than-30% guide, with 2027 described as… The bear view: A bullish customer print bought nothing. Both cases follow in full.

Bull Case

• Customer capex read-through strengthened, 2026-08-13: Applied Materials posted record revenue of $9.115B (+25% YoY, +15% QoQ) and non-GAAP EPS of $3.50 (+41% YoY), and raised its Semi Systems growth expectation above the prior greater-than-30% guide, with 2027 described as another strong AI-led year. Applied is one of the two customers behind roughly 90% of Ichor revenue.
• Q3 guide sits above the Street, 2026-08-03: revenue $315–345M against $314.523M consensus; non-GAAP diluted EPS $0.40–0.50 against $0.41; GAAP diluted EPS $0.25–0.35 against $0.25. Management stated the growth forecast for Q2 has already been booked into Q3.
• Growth rate intact: Q2 revenue $294.8M, +24% YoY from $240.3M and +15% sequentially from Q1's $256.1M, with gross margin at 13.9% versus 11.3% a year earlier.
• Balance sheet funded: cash and equivalents $256.5M at Q2-end, up $167.4M sequentially, against total debt of $120.6M.
• Sell-side has not capitulated: consensus 12-month target of $95.86 across 7 analysts with a Strong Buy consensus rating as of 2026-08-21 — 59% above the $60.20 close. Riley $125→$105 (Buy), Needham raised to $88 (Buy), Oppenheimer raised to $80 (Perform).

Bear Case

• A bullish customer print bought nothing. Applied's 2026-08-13 beat-and-raise was followed by Ichor closing $60.20 on 2026-08-21, below the 2026-08-07 close of $68.32 and through the 2026-06-05 low of $62.91. When the strongest available demand datapoint fails to hold a stock, the marginal buyer is not underwriting demand.
• Insiders kept selling into the drawdown. Director Iain MacKenzie sold 9,933 ordinary shares on 2026-08-18 at weighted average prices of $65.19–$68.14 under a 10b5-1 plan;
• The issuer sold stock 34% higher. The $200M at-the-market program completed in Q2 placed 2.5 million shares at an average of $80.70 — well above the 2026-08-21 close, against roughly 37.45 million shares outstanding.
• Cash went the wrong way in a record quarter: Q2 operating cash flow -$15.9M, free cash flow -$23.6M, inventories $290.7M. Revenue growth is not converting.
• Thin absorption cushion: Q2 GAAP gross margin 13.9%, Q3 guided 14.5–15.5%. A mid-teens-margin assembler has little buffer if the build rate slips even while end demand holds.
• The valuation anchor is stale. A $95.86 consensus target against a $60.20 close is a 59% gap that resolves either by price recovering or by targets converging down; the 2026-08-04 revisions already showed the direction of travel from the top ($115→$100, $125→$105).
• The name was already flagged into weakness: Benzinga's 2026-06-10 "5 Stocks to Sell as Semiconductor Rally Stalls" listed it before the June–August unwind.

Setup & Price Structure

• Reference close 2026-08-21: $60.20. That is a weekly close beneath the 2026-06-05 low of $62.91, which was the last higher-low supporting the June breakout leg. The break happened on the week after a positive customer catalyst, not on a negative one.
• Overhead supply is layered and close together: $62.91 (June low, now resistance on any reclaim), $68.32 (2026-08-07 close), $69.94 (2026-08-03 after-hours print), $78 (April–May ceiling and June breakout shelf), $80.25/$80.70 (the 2026-08-03 close and the average price at which the company itself issued stock).
• RSI(14) at 26.8 is an oversold reading, not a base. No higher-low has formed since 2026-08-03, and the distance from the $112.28 52-week high is 46.4%.
• Crowding and positioning observables: equity issued into strength (2.5M shares at an $80.70 average, completed Q2); three insider dispositions dated 2026-06-02, 2026-08-18 and 2026-08-19, all pre-scheduled plan sales; sell-side targets clustered 46–75% above spot and not yet re-cut after the August break; no company earnings date inside the next 30 days, so there is no imminent print to compress the range. A withholding, not an open-market sale.
• What a rebuild would look like, stated so it is checkable: a weekly close back above $62.91 followed by a higher low, and then acceptance above the $68–70 band that framed the post-print reversal.

Catalyst Calendar (next 30 days)

• No confirmed Ichor-dated event before 2026-09-21. The nearest company report is the Q3 print at roughly 2026-11-02 (est.) — confirm on Ichor IR. This matters on its own: nothing resolves the margin or cash-conversion question for about ten weeks.
• ~2026-09-24 (est.) — Micron fiscal Q4 2026 results. Falls just outside the 30-day window. The cleanest external check on whether DRAM/NAND capex is being funded into 2027, which is the assumption under Ichor's "at least 30% FY2026 revenue growth" framing.
• Late October 2026 (date unconfirmed) — Lam Research fiscal Q1. Lam is the other half of the ~90% customer concentration; its CY2027 WFE framing re-prices Ichor's forward revenue independently of anything Ichor says.

Elapsed catalysts

• Ongoing, undated — Form 4 flow. The 10b5-1 plans that produced the 2026-08-18 and 2026-08-19 sales continue to file; the observable is whether dispositions continue below $65. (passed 7d ago)

What Would Change Our Mind

The load-bearing observation is that Applied's 2026-08-13 beat-and-raise did not hold the stock. Reverse that and the read changes: a weekly close back above $62.91 that then holds on a retest, with Micron's ~2026-09-24 (est.) print confirming 2027 memory capex, would argue the August break was liquidation into an unrevised sell-side target set rather than the end of the leg. A renewed rating action upward — any house re-raising above the 2026-08-04 cuts — would corroborate it.

Downside, stated as a gradeable condition: a weekly close below $58 confirms the oversold RSI(14) reading of 26.8 resolved lower and that no base is forming under the lost $62.91 floor. A secondary break is Q3 revenue landing under the $315M low end of guidance, or gross margin printing below the 14.5% guide floor, at the ~2026-11-02 (est.) report — either would move the story from "multiple compression despite demand" to "the demand did not convert".

The thesis would also be void in the other direction on evidence of renewed dilution: a new at-the-market authorisation or prospectus supplement in an 8-K/S-3, or a share count in the Q3 10-Q above the roughly 37.45 million base, would show management funding working capital with stock at prices far below the $80.70 average it achieved in Q2.

Correlation Notes

• Direct customer beta: roughly 90% of revenue routes through Lam Research and Applied Materials. Ichor is a levered derivative of those two capex guides, with the added twist that on 2026-08-13 the derivative did not follow the underlying — Applied itself fell 4.94% after hours to $508.15 despite the beat, on near-term margin guidance.
• Nearest listed comp: Ultra Clean Holdings, the other US-listed WFE subsystem assembler, shares the same customer concentration and the same mid-teens gross-margin structure; divergence between the two isolates company-specific issues from sector ones.
• Memory read-through: Micron's fiscal Q4 (~2026-09-24 est.) and DRAM/NAND pricing set the funding assumption behind Ichor's 2027 visibility claim.
• Index context: the name trades with SOXX/SMH but at materially higher beta on the way down — 46.4% below its 52-week high while Applied's Semi Systems outlook was being raised.